Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4).
about
Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.Dalteparin sodium.Bioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers.Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network.Life-threatening hemorrhage after dalteparin therapy in a patient with impaired renal function.
P2860
Inhibition of thrombin generation by heparin and low molecular weight (LMW) heparins in the absence and presence of platelet factor 4 (PF4).
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Inhibition of thrombin generat ...... ce of platelet factor 4 (PF4).
@en
type
label
Inhibition of thrombin generat ...... ce of platelet factor 4 (PF4).
@en
prefLabel
Inhibition of thrombin generat ...... ce of platelet factor 4 (PF4).
@en
P2093
P2860
P1476
Inhibition of thrombin generat ...... ce of platelet factor 4 (PF4).
@en
P2093
Barrowcliffe TW
P2860
P304
P356
10.1111/J.1365-2141.1992.TB06437.X
P407
P577
1992-10-01T00:00:00Z